Publication | Closed Access

The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo

InflammationAsthmaProtein InhibitorAllergyLeukotriene BiosynthesisRespiratory ToxicologyMedicineLipid PeroxidationImmunologyPulmonary PharmacologyPharmacologyAsthmatic SubjectsOxidative Stress